Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.470
+0.010 (0.68%)
Apr 28, 2025, 4:00 PM EDT - Market closed

Pliant Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
908011,085943487806
Upgrade
Market Cap Growth
-26.11%-26.11%15.09%93.72%-39.65%-
Upgrade
Enterprise Value
-205457573599265512
Upgrade
Last Close Price
1.4713.1718.1119.3313.5022.72
Upgrade
PS Ratio
--686.5397.3264.2519.28
Upgrade
PB Ratio
0.292.642.293.012.442.85
Upgrade
P/TBV Ratio
0.302.642.293.012.442.85
Upgrade
EV/Sales Ratio
--362.7861.8435.0612.25
Upgrade
Debt / Equity Ratio
0.200.200.020.050.04-
Upgrade
Asset Turnover
--0.000.030.030.20
Upgrade
Quick Ratio
10.7810.7817.4313.9812.0724.71
Upgrade
Current Ratio
10.9110.9117.7214.2312.4425.07
Upgrade
Return on Equity (ROE)
-54.09%-54.09%-41.00%-48.13%-40.35%-21.13%
Upgrade
Return on Assets (ROA)
-31.40%-31.40%-26.68%-27.81%-23.59%-12.56%
Upgrade
Return on Capital (ROIC)
-33.61%-33.61%-28.27%-29.70%-24.92%-13.24%
Upgrade
Earnings Yield
-233.06%-26.24%-14.87%-13.08%-19.99%-5.15%
Upgrade
FCF Yield
-176.59%-19.88%-10.81%-10.23%-15.91%-4.81%
Upgrade
Buyback Yield / Dilution
-3.10%-3.10%-39.75%-17.21%-67.94%-1214.82%
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q